ATRICURE INC's ticker is ATRC and the CUSIP is 04963C209. A total of 217 filers reported holding ATRICURE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,330,278 | -61.0% | 56,219 | -63.2% | 0.24% | -31.8% |
Q3 2022 | $5,976,000 | +37.2% | 152,834 | +43.4% | 0.35% | +36.8% |
Q2 2022 | $4,356,000 | -80.3% | 106,615 | -68.3% | 0.25% | -64.7% |
Q1 2022 | $22,106,000 | -15.5% | 336,615 | -10.5% | 0.72% | -24.3% |
Q4 2021 | $26,152,000 | -21.5% | 376,131 | -21.5% | 0.95% | -6.6% |
Q3 2021 | $33,335,000 | -25.7% | 479,293 | -15.2% | 1.01% | -27.4% |
Q2 2021 | $44,851,000 | +2.8% | 565,370 | -15.1% | 1.40% | +12.3% |
Q1 2021 | $43,620,000 | +9.5% | 665,750 | -7.0% | 1.24% | -14.2% |
Q4 2020 | $39,840,000 | +38.7% | 715,649 | -0.6% | 1.45% | -2.2% |
Q3 2020 | $28,729,000 | -6.7% | 720,003 | +5.1% | 1.48% | -50.0% |
Q2 2020 | $30,803,000 | -3.9% | 685,273 | -28.2% | 2.96% | -22.1% |
Q1 2020 | $32,044,000 | +1063.1% | 953,994 | +959.6% | 3.81% | +592.0% |
Q4 2018 | $2,755,000 | +16.2% | 90,030 | +33.0% | 0.55% | +10.2% |
Q3 2018 | $2,370,000 | +52.3% | 67,670 | -38.5% | 0.50% | -24.5% |
Q2 2016 | $1,556,000 | -25.1% | 110,098 | -10.8% | 0.66% | -30.1% |
Q1 2016 | $2,078,000 | +91.2% | 123,450 | +154.8% | 0.94% | +105.9% |
Q4 2015 | $1,087,000 | – | 48,450 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 350,000 | $13,965,000 | 4.30% |
SECTORAL ASSET MANAGEMENT INC | 708,717 | $28,278,000 | 2.43% |
First Light Asset Management, LLC | 561,018 | $22,385,000 | 2.29% |
DAFNA Capital Management LLC | 133,229 | $5,316,000 | 1.73% |
PERKINS CAPITAL MANAGEMENT INC | 44,350 | $1,770,000 | 1.63% |
PURA VIDA INVESTMENTS, LLC | 645,003 | $25,736,000 | 1.33% |
Acuitas Investments, LLC | 46,353 | $1,849,000 | 1.30% |
EMERALD MUTUAL FUND ADVISERS TRUST | 477,064 | $19,035,000 | 0.84% |
EMERALD ADVISERS, LLC | 500,848 | $19,984,000 | 0.82% |
Orbimed Advisors | 1,228,189 | $49,005,000 | 0.62% |